Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihisa Ishikawa

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Genetics|November 20, 2014
Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapyToshihisa Ishikawa
Pharmacogenomics|July 31, 2012
Genetic variants in the human SLCO1B1 gene and individual variations in methotrexate clearanceToshihisa Ishikawa
Pharmacogenomics|April 21, 2012
Recent advances in pharmacogenomics of ABC transporters involved in breast cancer therapyToshihisa Ishikawa
Pharmaceutical Research|December 25, 2008
Emerging trends in human ABC transportersToshihisa Ishikawa
Advanced Drug Delivery Reviews|January 7, 2009
The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapyToshihisa Ishikawa
Pharmacogenomics|July 31, 2012
Identification of a novel locus associated with recurrence-free survival in Japanese breast cancer patients receiving adjuvant tamoxifen therapyToshihisa Ishikawa
Journal of Experimental Therapeutics & Oncology|February 24, 2005
The 24th International Symposium of Sapporo Cancer Seminar "Pharmacogenomics in Cancer Chemotherapy: Recent Advances in ABC Transporters and Genome Analyses". Hokkaido University Conference Hall, Sapporo, Japan, June 20-22, 2004Toshihisa Ishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 19, 2006
[Pharmacogenomics: current status and future prospectives]Toshihisa Ishikawa
Journal of Experimental Therapeutics & Oncology|October 16, 2009
Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomicsToshihisa Ishikawa, Hiroshi Nakagawa
Anti-Cancer Agents in Medicinal Chemistry|December 25, 2010
Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failureYu Toyoda, Toshihisa Ishikawa
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Genetics|November 20, 2014
Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapyToshihisa Ishikawa
Pharmacogenomics|July 31, 2012
Genetic variants in the human SLCO1B1 gene and individual variations in methotrexate clearanceToshihisa Ishikawa
Pharmacogenomics|April 21, 2012
Recent advances in pharmacogenomics of ABC transporters involved in breast cancer therapyToshihisa Ishikawa
Pharmaceutical Research|December 25, 2008
Emerging trends in human ABC transportersToshihisa Ishikawa
Advanced Drug Delivery Reviews|January 7, 2009
The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapyToshihisa Ishikawa
Pharmacogenomics|July 31, 2012
Identification of a novel locus associated with recurrence-free survival in Japanese breast cancer patients receiving adjuvant tamoxifen therapyToshihisa Ishikawa
Journal of Experimental Therapeutics & Oncology|February 24, 2005
The 24th International Symposium of Sapporo Cancer Seminar "Pharmacogenomics in Cancer Chemotherapy: Recent Advances in ABC Transporters and Genome Analyses". Hokkaido University Conference Hall, Sapporo, Japan, June 20-22, 2004Toshihisa Ishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 19, 2006
[Pharmacogenomics: current status and future prospectives]Toshihisa Ishikawa
Journal of Experimental Therapeutics & Oncology|October 16, 2009
Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomicsToshihisa Ishikawa, Hiroshi Nakagawa
Anti-Cancer Agents in Medicinal Chemistry|December 25, 2010
Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failureYu Toyoda, Toshihisa Ishikawa
Pageof 11